MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...
This library requires a complete Minecraft resource pack in order to function. This means a resource pack that include all models, blockstates, and textures. As most resource packs only include what ...
Lepton EDA is a suite of free software tools for designing electronics. It provides schematic capture, netlisting into over 30 netlist formats, and many other features. It was forked from the gEDA/gaf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback